Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    16678604 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Extending the Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated Ex Vivo Lung Perfusion (EVLP) Facility
Condition: Lung Transplantation
Intervention: Device: Toronto EVLP System™ performed by SPONSOR at SPONSOR's dedicated EVLP facility
2 Completed Ex-Vivo Lung Perfusion to Increase the Number of Organs for Transplantation
Conditions: Disorder Related to Lung Transplantation;   Brain Death;   Graft Failure;   Primary Graft Dysfunction
Intervention: Procedure: EVLP Group
3 Recruiting Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs
Condition: Lung Transplant
Intervention: Device: Ex vivo lung perfusion with Steen Solution™

Indicates status has not been verified in more than two years